SEC: No need for separate Sputnik Light phase-3 trials

SEC: No need for separate Sputnik Light phase-3 trials After detailed deliberation, the committee recommended that the firm should present the safety, immunogenicity and efficacy data of Phase-III clinical trial of Sputnik Light that is being carried out in Russia for considering the proposal for grant of MA in the country. https://ift.tt/eA8V8J